GC7 Grant Reprioritization and Revision: CCM/E 1st Extraordinary Meeting

On August 27, 2025, the Country Coordinating Mechanism of Ethiopia (CCM/E) held an extraordinary meeting to discuss the reprioritization and revision of Global Fund Grant Cycle 7 (GC7) grants. The revision was necessary to address a $58.5 million (13.1%) budget reduction from the Global Fund, bringing the total portfolio amount to $389.5 million.

The meeting was chaired by H.E. Semereta Sewasew, CCM/E Chairperson and State Minister of Finance, and Dr. Girmachew Mamo, CCM/E Vice-Chairperson. The primary goal of the grant revision exercise was to adapt to the new budget while protecting the most critical, lifesaving, high-impact interventions in the fight against HIV, Tuberculosis (TB), and Malaria.

The CCM/E leadership commended the transparent and inclusive nature of the grant revision exercise. They praised the Principal Recipient (PR), Sub-Recipients (SRs), and development partners for their tireless and collaborative work to prioritize impactful interventions and thanked the CCM/E Secretariat for its excellent coordination, which ensured the process was both swift and strategic.

Strategic Revisions Across the Grants

The reprioritization was a meticulous process, with each grant being carefully reviewed to maximize impact and maintain life-saving interventions.

HIV Grant: The budget was reduced by $28.9 million (12.1%) to a new total of $210 million. The revision prioritized funding for procurement of life-saving pharmaceuticals and health products essential for the continuity of diagnosis, treatment, and prevention service by reducing funding from programmatic and soft activities.

TB Grant: The original budget was reduced by $4.85 million (8.3%) to $53.5 million. While core services like case finding and treatment were protected, the program now faces a critical $38 million funding gap for commodities, including GeneXpert cartridges and first-line drugs. This remains a significant risk to the program requiring collective effort.

Malaria Grant: This reduction, coupled with a resurgence of malaria cases in the country, necessitates a strict focus on high-priority, life-saving interventions. Like the other grants, procurement of pharmaceuticals and health products was the utmost priority.

Resilient and Sustainable Systems for Health (RSSH) Grant: This grant faced the largest cut of $17.4 million (39.2%), with a new total of $27 million. Given the grant’s broad nature, prioritization was complex. Revisions focused on protecting high-impact activities and those supported by the matching fund for maximum efficiency.

Next Steps

The revised GC7 grant package, taking into consideration country context and now more focused and aligned with national health priorities, is ready for submission to the Global Fund. The CCM/E and its partners will now focus on mobilizing resources to close the critical funding gaps, especially TB commodities.